Commensal epitopes drive differentiation of colonic T.

The gut microbiome is the largest source of intrinsic non-self-antigens that are continuously sensed by the immune system but typically do not elicit lymphocyte responses. CD4 T cells are critical to sustain uninterrupted tolerance to microbial antigens and to prevent intestinal inflammation. However, clinical interventions targeting commensal bacteria-specific CD4 T cells are rare, because only a very limited number of commensal-derived epitopes have been identified. Here, we used a new approach to study epitopes and identify T cell receptors expressed by CD4Foxp3 (T) cells specific for commensal-derived antigens. Using this approach, we found that antigens from reprogram naïve CD4 T cells to the T lineage, expand preexisting microbe specific T, and limit wasting disease in the CD4 T cell transfer model of colitis. These data suggest that the administration of specific commensal epitopes may help to widen the repertoire of specific T that control intestinal inflammation.